GB0803019D0 - Fluorinated compounds - Google Patents

Fluorinated compounds

Info

Publication number
GB0803019D0
GB0803019D0 GBGB0803019.9A GB0803019A GB0803019D0 GB 0803019 D0 GB0803019 D0 GB 0803019D0 GB 0803019 A GB0803019 A GB 0803019A GB 0803019 D0 GB0803019 D0 GB 0803019D0
Authority
GB
United Kingdom
Prior art keywords
fluorinated compounds
fluorinated
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0803019.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
BTG International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BTG International Ltd filed Critical BTG International Ltd
Priority to GBGB0803019.9A priority Critical patent/GB0803019D0/en
Publication of GB0803019D0 publication Critical patent/GB0803019D0/en
Priority to PCT/GB2009/000391 priority patent/WO2009103950A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
GBGB0803019.9A 2008-02-19 2008-02-19 Fluorinated compounds Ceased GB0803019D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0803019.9A GB0803019D0 (en) 2008-02-19 2008-02-19 Fluorinated compounds
PCT/GB2009/000391 WO2009103950A1 (en) 2008-02-19 2009-02-13 Fluorinated pyridin-4-0nes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0803019.9A GB0803019D0 (en) 2008-02-19 2008-02-19 Fluorinated compounds

Publications (1)

Publication Number Publication Date
GB0803019D0 true GB0803019D0 (en) 2008-03-26

Family

ID=39271934

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0803019.9A Ceased GB0803019D0 (en) 2008-02-19 2008-02-19 Fluorinated compounds

Country Status (2)

Country Link
GB (1) GB0803019D0 (en)
WO (1) WO2009103950A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30986A1 (en) 2007-03-28 2008-09-02 Apotex Technologies Inc FLUORINATED DEFERIPRONE DERIVATIVES
PT2268282E (en) 2008-04-25 2015-02-05 Apotex Technologies Inc Liquid formulation for deferiprone with palatable taste
BR112012000079A2 (en) * 2009-07-03 2017-07-25 Apotex Tech Inc fluorinated derivatives of 3-hydroxypyridin-4-ones
US8592485B2 (en) * 2010-06-17 2013-11-26 Healthpartners Research Foundation Methods and pharmaceutical compositions for treating the animal central nervous system for psychiatric disorders
SI3608325T1 (en) 2012-12-21 2022-09-30 Gilead Sciences, Inc. Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
NO2865735T3 (en) 2013-07-12 2018-07-21
NO2717902T3 (en) 2014-06-20 2018-06-23
TWI744723B (en) 2014-06-20 2021-11-01 美商基利科學股份有限公司 Synthesis of polycyclic-carbamoylpyridone compounds
TW201613936A (en) 2014-06-20 2016-04-16 Gilead Sciences Inc Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
GB201420348D0 (en) * 2014-11-17 2014-12-31 Univ Northumbria Newcastle Compounds for treating neurodegenerative diseases
CN111170936B (en) * 2020-01-19 2021-01-01 杭州泽德医药科技有限公司 3, 4-dihydroxy-N- (1 '-benzyl-2' -hydroxyethyl) -2-methylpyridine chloride and preparation and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB9711093D0 (en) * 1997-05-29 1997-07-23 British Tech Group Novel orally active iron (III) chelators
UY30986A1 (en) * 2007-03-28 2008-09-02 Apotex Technologies Inc FLUORINATED DEFERIPRONE DERIVATIVES

Also Published As

Publication number Publication date
WO2009103950A1 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
GB0807862D0 (en) Compounds
GB0800035D0 (en) Compounds
GB0804702D0 (en) Compounds
GB0803019D0 (en) Fluorinated compounds
GB0809776D0 (en) Compounds
GB0807103D0 (en) Compounds
GB0800367D0 (en) Compounds
GB0807910D0 (en) Compounds
GB0801220D0 (en) Compounds
GB0801265D0 (en) Compounds
GB0811029D0 (en) Compounds
GB0808669D0 (en) Compounds
GB0800961D0 (en) Compounds
GB0801596D0 (en) Compounds
GB0800841D0 (en) Compounds
GB0802191D0 (en) Compounds
GB0802192D0 (en) Compounds
GB0802231D0 (en) Compounds
GB0802586D0 (en) Compounds
GB0802587D0 (en) Compounds
GB0811450D0 (en) Compounds
GB0811449D0 (en) Compounds
GB0811203D0 (en) Compounds
GB0800455D0 (en) Compounds
GB0810892D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)